Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, and the Faculty of Health Sciences, University of Copenhagen, Herlev, Denmark.
CMAJ. 2012 Jan 10;184(1):E57-69. doi: 10.1503/cmaj.110167. Epub 2011 Nov 28.
Patients surviving certain types of cancer are at increased risk of a second primary cancer. We tested the hypothesis that excess risk of a second primary cancer is due mainly to excess risk of it being the same type of cancer as the first, rather than to excess risk of it being a different type.
We conducted a nationwide study using data from three dabatases for the entire Danish population (n = 7,493,705) from 1980 through 2007. For each type of cancer, we performed a nested study matching each patient with incident cancer diagnosed in that period with up to five controls who did not have the examined cancer at the time of diagnosis. We used Cox regression models to calculate individual risk estimates and meta-analysis techniques to calculate aggregated risk estimates.
A total of 765,255 people had one or more diagnoses of primary cancer (total 843,118 diagnoses) during the study period. The aggregated hazard ratio (HR) for risk of any second primary cancer after any first cancer was 1.25 (95% confidence interval [CI] 1.24-1.26), with heterogeneity among cancer types. The aggregated HR for risk of a second primary cancer of the same type as the first was 2.16 (95% CI 1.98-2.34). The aggregated HR for risk of a second cancer of a different type from the first was 1.13 (95% CI 1.12-1.15). Results were similar when we excluded second primary cancers occurring within 1, 2, 5 or 10 years after the first cancer. Overall, we observed 74 significant associations among 27 types of first cancer and 27 possible types of second primary cancer.
Excess risk of a second primary cancer was due mainly to a 2.2-fold risk of the second cancer being the same type as the first, whereas the risk of it being a different type was only 1.1-fold. However, heterogeneity among cancer types was substantial.
某些类型癌症的存活患者患第二种原发性癌症的风险增加。我们检验了这样一种假说,即第二种原发性癌症的风险增加主要归因于其与第一种癌症相同类型的风险增加,而不是其为不同类型的风险增加。
我们使用来自三个数据库的数据在丹麦全国范围内进行了一项研究,该研究涵盖了 1980 年至 2007 年期间的全部人口(n=7493705 人)。对于每种癌症,我们进行了嵌套研究,将在此期间诊断出患有癌症的每个患者与多达五名未在诊断时患有检查癌症的对照者进行匹配。我们使用 Cox 回归模型计算个体风险估计值,并使用荟萃分析技术计算综合风险估计值。
在研究期间,共有 765255 人有一次或多次原发性癌症诊断(共 843118 次诊断)。任何首次癌症后发生第二种原发性癌症的总体风险比(HR)为 1.25(95%置信区间[CI]1.24-1.26),不同癌症类型之间存在异质性。与首次癌症相同类型的第二种原发性癌症的总体 HR 为 2.16(95%CI1.98-2.34)。与首次癌症不同类型的第二种癌症的总体 HR 为 1.13(95%CI1.12-1.15)。当我们排除首次癌症后 1、2、5 或 10 年内发生的第二种原发性癌症时,结果相似。总体而言,我们在 27 种首次癌症和 27 种可能的第二种原发性癌症之间观察到 74 种显著关联。
第二种原发性癌症的风险增加主要归因于第二种癌症与第一种癌症相同类型的风险增加了 2.2 倍,而不同类型的风险仅增加了 1.1 倍。然而,癌症类型之间存在很大的异质性。